Literature DB >> 8953530

Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51.

S C Olsen1, D Evans, S G Hennager, N F Cheville, M G Stevens.   

Abstract

This study was designed to determine if Brucella abortus strain RB51, which expresses small amounts of the lipopolysaccharide O side chain, would cause positive responses on brucellosis serologic surveillance tests when given to adult cattle that were vaccinated as calves with B. abortus strain 19. Cattle vaccinated as adults with strain RB51 that had been vaccinated as calves with strain 19 (n = 40) had significantly greater antibody titers (P < 0.05) against strain RB51 at 4 and 8 weeks postvaccination in the dot blot assay than did animals (n = 10) not vaccinated with strain RB51. When evaluated using the card or buffered acid plate agglutination presumptive tests, 7 strain RB51 vaccinates tested positive at either 4 or 8 weeks following vaccination as compared with 4 cattle in the control group that were not vaccinated with strain RB51. One strain RB51 vaccinate was scored as suspect on the standard tube agglutination (STA) test at 8 weeks following vaccination. Remaining samples from strain RB51 vaccinates tested negative on the STA, complement fixation (CF), rivanol, and particle concentration fluorescence immunoassay (PCFIA) confirmatory tests. Samples from 2 control cattle were PCFIA positive at time 0; 1 of these animals was CF positive throughout the study. This study suggests that use of strain RB51 in cattle vaccinated with strain 19 as calves will not cause positive responses on confirmatory tests and will not impair brucellosis serologic surveillance efforts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8953530     DOI: 10.1177/104063879600800408

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Comparative study on responses of cattle and water buffalo (Bubalus bubalis) to experimental inoculation of Brucella abortus biovar 1 by the intraconjunctival route--a preliminary report.

Authors:  Abiodun A Adesiyun; Geoff T Fosgate; Anil Persad; Mervyn Campbell; Ravi Seebaransingh; Alva Stewart-Johnson
Journal:  Trop Anim Health Prod       Date:  2010-07-08       Impact factor: 1.559

2.  Brucella abortus RB51 and hot saline extract from Brucella ovis as antigens in a complement fixation test used To detect sheep vaccinated with Brucella abortus RB51.

Authors:  R Adone; F Ciuchini
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice.

Authors:  Carlos A Velikovsky; Juliana Cassataro; Guillermo H Giambartolomei; Fernando A Goldbaum; Silvia Estein; Raul A Bowden; Laura Bruno; Carlos A Fossati; Moisés Spitz
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Genetic bases of the rifampin resistance phenotype in Brucella spp.

Authors:  Cinzia Marianelli; Franco Ciuchini; Michela Tarantino; Paolo Pasquali; Rosanna Adone
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Selection of protective epitopes for Brucella melitensis by DNA vaccination.

Authors:  Xinghong Yang; Mary Hudson; Nancy Walters; Robert F Bargatze; David W Pascual
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

6.  Influence of species of negative control sera on results of a brucellosis fluorescence polarization assay.

Authors:  Steven C Olsen; Lauren S Crawford; Antonio Fuentes; Miladin Kostovic; Paola M Boggiatto
Journal:  J Vet Diagn Invest       Date:  2020-11-19       Impact factor: 1.279

7.  Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice.

Authors:  Jeong Ju Lim; Dong Hyeok Kim; Jin Ju Lee; Dae Geun Kim; Wongi Min; Hu Jang Lee; Man Hee Rhee; Suk Kim
Journal:  J Vet Sci       Date:  2012-09       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.